Comparative Analysis of Clinical Efficacy of Different Glaucoma Treatment Regimens

1. Huang WQ, Huang QR, Li CX. Efficacy analysis of different surgical schemes for the treatment of angle-closure glaucoma combined with cataract. Chinese Pract Med. 2025;20(02):58–61.

2. Haszcz CA, Gołaszewska K, Żarnowski T, Kosior-Jarecka E, Konopińska J. Revolution in glaucoma treatment: a review elucidating canaloplasty and gonioscopy-assisted transluminal trabeculotomy as modern surgical alternatives. Front Med. 2025;121494391–1494391. Available from: https://doi.org/10.3389/fmed.2025.1494391

3. Liu J, Liang Y, Tian Y, Sun X, Lei Y, Lei P. Unlocking the Untapped Potential of Photoresponsive Dual-Gas Nanomedicine in Glaucoma Therapy. Adv Healthc Mater. 2025:e2404245. Available from: https://doi.org/10.1002/adhm.202404245

4. Irkec M, Konstas GA, Holló G, Dikmetaş Ö, Algedik Tokyürek MÖ. Investigational drugs for glaucoma: novel mechanistic approaches of preclinical agents. Expert Opin Investig Drugs. 2025;34(3):231–43. Available from: https://doi.org/10.1080/13543784.2025.2472409

5. Shi FY. Efficacy analysis of modified scleral tunnel glaucoma valve implantation for refractory glaucoma. Syst Med. 2025;10(03):44–7. Available from: http://dx.doi.org/10.1097/IJG.0000000000000463

6. Yao P, Lu JY, Yang HT. Efficacy of multioperative treatment for true microphthalmia secondary to angle-closure glaucoma. Chin Med Guide. 2025;23(07):26–30.

7. Wang M. Analysis of the effect of combined surgery on chronic angle-closure glaucoma and cataract. China Mod Drug Appl. 2025;19(02):48–51.

8. Umapathi MR, Hliang NT, Min SKA, Sim C, Perera SA, Husain R. Characteristics of eyes with asymptomatic primary angle closure glaucoma with varying severity of visual field loss at presentation. J Glaucoma. 2025;34(5):358–64. Available from: https://doi.org/10.1097/ijg.0000000000002554

9. Kaiyoor DS, Rengappa R. A comparative study of complications and its management following phaco-trabeculectomy in primary open angle glaucoma, primary angle closure glaucoma and pseudo-exfoliative glaucoma with cataract. Indian J Clin Exp Ophthalmol. 2019;5(1):121–6. Available from: https://researchersprofile.com/abstract/9058

10. Lee JE, Park YD, Park MH, et al. Enlargement of microvascular dropout toward the disc-fovea axis indicates new central visual field defect in glaucoma. Sci Rep. 2025;15(1):11052. Available from: https://doi.org/10.1038/s41598-025-87245-8

11. Wrześniewska M, Dyda M, Skowron P, Tomecka P, Zontek K, Brawańska K. Complications after gonioscopy-assisted transluminal trabeculotomy in glaucoma treatment - literature review. Folia Med Cracov. 2024;64(2):51–62. Available from: https://doi.org/10.24425/fmc.2024.150151

12. Masaaki Y, Yu Y, Taiki K, Tsuda S, Himori N, Maekawa S. Long-term surgical outcomes and possible postoperative complication with severe corneal endothelial cell loss after trabeculectomy for cytomegalovirus-associated anterior uveitis with secondary glaucoma. Ocul Immunol Inflamm. 2023:1–9. Available from: http://dx.doi.org/10.1080/09273948.2023.2197497

13. Arenstorff VMM, Ahmadzadeh A, Schmidt SB, Kessel L, Bach-Holm D. Vision-related quality of life in patients with glaucoma before and after trabeculectomy. Acta Ophthalmol. 2024;102(7):779–89. Available from: https://doi.org/10.1111/aos.16697

14. Yuxin F, Xiaoming D, Lin C, Shi J, Liu J, Sun Y. Combination of trabeculectomy and primary pars plana vitrectomy in the successful treatment of angle-closure glaucoma with BEST1 mutations: self-controlled case series. Ophthalmol Ther. 2022;11(6):2271–84. Available from: https://doi.org/10.1007/s40123-022-00580-1

15. Zhu Y, Moksha L, Salowe R, Vrathasha V, Pham K, Aibo MI. Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds. Biomed Pharmacother. 2025;190:118319. Available from: https://doi.org/10.1016/j.biopha.2025.118319